![Suk-Young Hwang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Suk-Young Hwang
Comptroller/Controller/Auditor presso Celltrion Skincure Co., Ltd.
Posizioni attive di Suk-Young Hwang
Società | Posizione | Inizio | Fine |
---|---|---|---|
Celltrion Skincure Co., Ltd.
![]() Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Comptroller/Controller/Auditor | 29/03/2017 | - |
Storia della carriera di Suk-Young Hwang
Precedenti posizioni note di Suk-Young Hwang
Società | Posizione | Inizio | Fine |
---|---|---|---|
CELLTRION HEALTHCARE CO., LTD. | Comptroller/Controller/Auditor | 29/03/2016 | - |
Direttore/Membro del Consiglio | 29/03/2016 | - |
Statistiche
Distribuzione geografica
Corea del Sud | 3 |
Posizioni
Comptroller/Controller/Auditor | 2 |
Director/Board Member | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Celltrion Skincure Co., Ltd.
![]() Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Health Technology |
Celltrion Healthcare Co., Ltd.
![]() Celltrion Healthcare Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. Its products include infliximab, rituximab, and trastuzumab biosimilars. The company was founded on December 29, 1999 and is headquartered in Incheon, South Korea. | Health Technology |
- Borsa valori
- Insiders
- Suk-Young Hwang
- Esperienza